Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, et al
[8] Those data are important for target biology in neuropathic-pain systems, but they do not establish LanCL1 as the mediator of adipocyte lipolysis, fat oxidation, or body-weight effects
MT2 is supplied as a lyophilised powder for in-vitro laboratory research only, not for human or veterinary use
evidence largely from GH-deficient populations but physiologically plausible in somatopause A note on evidence grading: most CJC-1295 human data comes from short-term pharmacokinetic trials rather than long-term outcome studies
Exclusion criteria included studies that were unpublished/abstract only or book chapters and were not relevant to the topic of the review